<div id="readability-page-1"><p>In a report released yesterday, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Alector, with a price target of <span id="expert-recommendation-target">$5.00</span>. The company’s shares closed yesterday at $1.14.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>According to TipRanks, Fein is a 5-star analyst with an average return of <span>26.5%</span> and a 54.36% success rate. Fein covers the Healthcare sector, focusing on stocks such as Alector, Prothena, and Palvella Therapeutics.</p> <p>Alector has an analyst consensus of Hold, with a price target consensus of $2.06.</p></div>

ALEC

<p>H.C. Wainwright's Andrew Fein reiterated a Buy rating on Alector with a $5.00 price target. Alector's shares closed at $1.14. Fein, a 5-star analyst, has a 26.5% average return and a 54.36% success rate. Alector's analyst consensus is Hold, with a $2.06 price target consensus.</p>

H.C. Wainwright Remains a Buy on Alector (ALEC)